Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Hikma Pharmaceuticals PLC?

Accepted Answer

Según el último estado financiero (Form-10K), Hikma Pharmaceuticals PLC tiene un total de activos de $5,133, una ganancia neta profit de $359

Question 2

¿Cuáles son los ratios financieros clave para HKMPY?

Accepted Answer

El ratio corriente de Hikma Pharmaceuticals PLC es 1.81, el margen neto es 11.37, las ventas por acción son $14.12.

Question 3

¿Cómo se desglosan los ingresos de Hikma Pharmaceuticals PLC por segmento o geografía?

Accepted Answer

Hikma Pharmaceuticals PLC largest revenue segment is Injectables, at a revenue of 1,022,059,311 in the most earnings release.For geography, United States is the primary market for Hikma Pharmaceuticals PLC, at a revenue of 1,476,742,665.

Question 4

¿Es rentable Hikma Pharmaceuticals PLC?

Accepted Answer

yes, según los últimos estados financieros, Hikma Pharmaceuticals PLC tiene una ganancia neta profit de $359

Question 5

¿Tiene Hikma Pharmaceuticals PLC alguna deuda?

Accepted Answer

yes, Hikma Pharmaceuticals PLC tiene una deuda de 2,823

Question 6

¿Cuántas acciones en circulación tiene Hikma Pharmaceuticals PLC?

Accepted Answer

Hikma Pharmaceuticals PLC tiene un total de acciones en circulación de 221.88

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,244	3,156	2,875	2,517	2,553	2,341
Revenue Growth (YoY)	8%	10%	14%	-1%	9%	6%
Cost of Revenue	1,828	1,708	1,468	1,252	1,252	1,128
Gross Profit	1,416	1,448	1,407	1,265	1,301	1,213
Selling, General & Admin	566	568	544	509	488	464
Research & Development	153	141	149	144	143	137
Operating Expenses	814	819	785	756	742	687
Other Non Operating Income (Expenses)	0	-84	-14	-11	-13	-11
Pretax Income	462	455	281	233	544	558
Income Tax Expense	89	93	89	42	124	128
Net Income	371	359	190	188	421	431
Net Income Growth	30%	89%	1%	-55%	-2%	-11%
Shares Outstanding (Diluted)	222.42	223.49	222.36	225	233	238
Shares Change (YoY)	-1%	1%	-1%	-3%	-2%	-2%
EPS (Diluted)	1.66	1.6	0.85	0.83	1.8	1.81
EPS Growth	31%	88%	2%	-54%	0%	-9%
Free Cash Flow	228	329	404	305	409	240
Free Cash Flow Per Share	1.02	1.47	1.81	1.35	1.75	1
Gross Margin	43.64%	45.88%	48.93%	50.25%	50.95%	51.81%
Operating Margin	18.55%	19.93%	21.63%	20.22%	21.89%	22.46%
Profit Margin	11.43%	11.37%	6.6%	7.46%	16.49%	18.41%
Free Cash Flow Margin	7.02%	10.42%	14.05%	12.11%	16.02%	10.25%
EBITDA	775	797	881	881	704	617
EBITDA Margin	23.89%	25.25%	30.64%	35%	27.57%	26.35%
D&A For EBITDA	173	168	259	372	145	91
EBIT	602	629	622	509	559	526
EBIT Margin	18.55%	19.93%	21.63%	20.22%	21.89%	22.46%
Effective Tax Rate	19.26%	20.43%	31.67%	18.02%	22.79%	22.93%

Hikma Pharmaceuticals PLC (HKMPY) Price

HKMPY Stock Price Chart

HKMPY Income

Follow-Up Questions